申请人:ABBVIE INC
                            
                            
                                公开号:WO2013096223A1
                            
                            
                                公开(公告)日:2013-06-27
                            
                            Disclosed herein are compounds of formula (I), or pharmaceutically acceptable salts thereof, wherein X1, L, Rx, Ry, Rz, A, m, n, p, q, s, and positions a and b are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.